Skip to content
  • Home
  • About us
  • Contact Us
Menu
  • Home
  • About us
  • Contact Us
  • General
  • Industry
  • Sports
  • Technology
  • Government & Politics
  • Health Maintenance
  • Press Releases
Menu
  • General
  • Industry
  • Sports
  • Technology
  • Government & Politics
  • Health Maintenance
  • Press Releases
Search
Close this search box.
  • December 8, 2025

Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy

December 8, 2025

Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy Leave a reply RICHARDSON, Texas, Dec.

Read More

Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

December 8, 2025

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after

Read More

Bitget October 2025 Protection Fund Maintains $741M Average Despite Slumptober

December 8, 2025

Bitget October 2025 Protection Fund Maintains $741M Average Despite Slumptober Bitget October 2025 Protection Fund Maintains $741M Average Despite Slumptober VICTORIA, Seychelles, Dec. 08, 2025

Read More

EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025

December 8, 2025

EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025 Leave a reply Recognition follows a vote by professional and active

Read More

Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows

December 8, 2025

Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows Leave a reply LONDON, Dec. 08, 2025 (GLOBE NEWSWIRE) — A sharp

Read More

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

December 8, 2025

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH)

Read More
Previous Page1 Page2 Page3 … Page17 Next
  • Recent Post

Qatar National Cement Company’s Net Profit Increases 0.21 Percent in H1 2026

July 22, 2026

European Stocks Open Lower

July 22, 2026

Lesha Bank’s Net Profit Jumps 50 Percent in H1 2026

July 22, 2026

Exchange Rates and Precious Metals Prices in Qatar Updated

July 22, 2026

Gold Rises to Two-Week High of $4,113.73 an Ounce Amid Middle East Tensions

July 22, 2026

Slightly Cloudy Weather Expected Tonight in Qatar

July 22, 2026

Join us as we navigate the ever-changing world of news, offering unique perspectives and meaningful stories that resonate with our readers. Whether you are interested in local news, international affairs, or market updates, Jazira Newswire is here to provide you with the information you need to make informed decisions. Trust us to bring you reliable and comprehensive coverage across a broad spectrum of subjects to deliver comprehensive coverage of global events. We are driven by a commitment to providing timely and accurate information on a wide range of topics. Our team is passionate about delivering news that matters, and keeping our readers informed and engaged.read more

Copyright © 2026 jaziranewswire.qa. All Rights Reserved.